Related Experiment Video
Updated: Mar 30, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1
Pankaj Pandey1, Ayat Hesham Zagzoog2, Theodor Zaharia2
1National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38655, USA.
Abstract:
While Δ9-tetrahydrocannabinol (THC) offers significant pain relief, its psychoactive side effects limit its clinical utility. The discovery of cannabidiol (CBD) as a negative allosteric modulator (NAM) of cannabinoid receptor 1 (CB1R) establishes allosteric targeting as a viable framework for refining cannabinoid-based therapeutics. Cannabidiphorol (CBDP), a naturally occurring homolog of CBD identified from the FM2 chemovar of Cannabis sativa, is structurally similar to CBD but its pharmacology is largely unexplored. This study investigated the potential of CBDP as a NAM of CB1R. Site-directed mutagenesis, in vitro CB1R allosterism assays and molecular dynamics analyses revealed that CBDP acts as an NAM by stably engaging two distinct allosteric sites: the established ORG27569 site and an intracellular site located between transmembrane helices 1, 2, 6, 7, and helix 8. In vivo, tetrad assays and novel object recognition (NOR) testing in male C57BL/6NHsd mice suggested that CBDP co-administration with THC was associated with modest modulation of cognitive performance relative to THC alone, while THC's antinociceptive effects were preserved. These findings identify CBDP as a possible dual-site CB1R NAM and support future studies to evaluate its potential therapeutic and mechanistic utility.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
03:43Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
Related Concept Videos
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Opioid Receptors: Overview
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism